Taibang Biological Group Overview
- Year Founded
-
2002
- Status
-
Private
- Employees
-
2,269
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
17
- Investments
-
5
Taibang Biological Group General Information
Description
Manufacturer of plasma-derived biological materials intended for therapeutic and preventive healthcare applications. The company has specifications covering three categories of human albumin, human immunoglobulin, and human coagulation factors and includes the research and development, production and sales of blood products and biological products, providing clients with blood and biopharmaceutical products as per their business requirements.
Contact Information
Website
www.chinabiologic.comCorporate Office
- Number 9-5, Jiangtai West Road
- Chaoyang District
- Beijing
- China
Corporate Office
- Number 9-5, Jiangtai West Road
- Chaoyang District
- Beijing
- China
Taibang Biological Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Taibang Biological Group Comparisons
Industry
Financing
Details
Taibang Biological Group Competitors (54)
One of Taibang Biological Group’s 54 competitors is Grifols, a Corporation company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Grifols | Corporation | Barcelona, Spain | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Techpool | Venture Capital-Backed | Guangzhou, China | ||||
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA |
Taibang Biological Group Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Taibang Biological Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Taibang Biological Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Taibang Biological Group Investments & Acquisitions (5)
Taibang Biological Group’s most recent deal was a Merger/Acquisition with Beijing Tianxinfu Medical Appliance for . The deal was made on 12-Oct-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Beijing Tianxinfu Medical Appliance | 12-Oct-2017 | Merger/Acquisition | Therapeutic Devices | ||
| Guizhou Taibang Biological Products | 26-Oct-2016 | Secondary Transaction - Private | Medical Supplies | ||
| Guizhou Taibang Biological Products | 04-Sep-2014 | Secondary Transaction - Private | Medical Supplies | ||
| Xi'an Huitian Blood Products | 23-Mar-2009 | Secondary Transaction - Private | Pharmaceuticals | ||
| Guizhou Taibang Biological Products | 01-Dec-2008 | Merger/Acquisition | Medical Supplies |
Taibang Biological Group Exits (1)
Taibang Biological Group’s most recent exit was on 23-Mar-2009 from Xi'an Huitian Blood Products. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Xi'an Huitian Blood Products | 23-Mar-2009 | Completed |
|
Taibang Biological Group Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Beijing Tianxinfu Medical Appliance | Beijing, China | 2002 |
Taibang Biological Group FAQs
-
When was Taibang Biological Group founded?
Taibang Biological Group was founded in 2002.
-
Where is Taibang Biological Group headquartered?
Taibang Biological Group is headquartered in Beijing, China.
-
What is the size of Taibang Biological Group?
Taibang Biological Group has 2,269 total employees.
-
What industry is Taibang Biological Group in?
Taibang Biological Group’s primary industry is Pharmaceuticals.
-
Is Taibang Biological Group a private or public company?
Taibang Biological Group is a Private company.
-
What is Taibang Biological Group’s current revenue?
The current revenue for Taibang Biological Group is .
-
How much funding has Taibang Biological Group raised over time?
Taibang Biological Group has raised $300M.
-
Who are Taibang Biological Group’s investors?
LH Ventures (China), Abu Dhabi Investment Authority, China Life Private Equity, GIC Private, and Kunpeng Capital are 5 of 12 investors who have invested in Taibang Biological Group.
-
Who are Taibang Biological Group’s competitors?
Grifols, Intas Pharmaceuticals, Techpool, Johnson&Johnson Innovative Medicine, and Dicerna Pharmaceuticals are some of the 54 competitors of Taibang Biological Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
